This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hansa Medical Ab. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Oonagh Shannon: Innovator in Immunoglobulin G Mediated Disease Treatment
Introduction
Oonagh Shannon is a notable inventor based in Veberod, Sweden. She has made significant contributions to the field of medicine, particularly in the treatment of diseases mediated by immunoglobulin G (IgG) antibodies. Her innovative work has led to the development of a unique therapeutic approach that holds promise for patients suffering from related conditions.
Latest Patents
Oonagh Shannon holds a patent for the invention titled "Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases." This patent describes the use of an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, in the manufacture of a medicament aimed at treating or preventing diseases mediated by IgG antibodies. This groundbreaking invention has the potential to change the landscape of treatment options available for these conditions. She has 1 patent to her name.
Career Highlights
Oonagh Shannon is currently associated with Hansa Medical AB, a company known for its innovative approaches in the medical field. Her work at Hansa Medical AB has allowed her to collaborate with other experts and contribute to advancements in therapeutic solutions.
Collaborations
Oonagh has worked alongside notable colleagues such as Mattias Collin and Rikard Holmdahl. Their combined expertise has fostered a collaborative environment that enhances the development of innovative medical treatments.
Conclusion
Oonagh Shannon's contributions to the field of immunology and her innovative patent highlight her role as a leading inventor in the medical community. Her work continues to inspire advancements in the treatment of IgG mediated diseases.